Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Gain After First Solar Rallies

First Solar, Inc. (FSLR) rallies today after Bloomberg suggested that the company could be takeover target for GE or Siemens. Analysts believe FSLR is a lot cheaper than it should be. FSLR closed at $31.80 on Wednesday, while the stock is trading at $34.22 at 1:00PM EST on Thursday, up 7.61% or $2.42.

MAVERICK CAPITAL

Here is a list of hedge funds that may reveal large gains due to FSLR’s price rise.

1. Maverick Capital – Lee Ainslie: gains $8.67 million

2. Generation Investment Management – David Blood and Al Gore: gains $3.26 million

3. Legg Mason Capital Management – Bill Miller: gains $841 thousand

4. David E. Shaw – D. E. Shaw: gains $819 thousand

5. Mason Capital Management – Kenneth Mario Garschina: gains $513 thousand

6. SAC Capital Advisors – Steven Cohen: gains $471 thousand

7. Coatue Management – Philippe Laffont: gains $419 thousand

8. Renaissance Technologies – Jim Simons: gains $410 thousand

9. Sandler Capital Management – Andrew Sandler: gains $363 thousand

10. Cavalry Asset Management – John Hurley: gains $330 thousand

DISCLAIMER: These calculations assume that these hedge funds did not increase or reduce their stock positions in FSLR since the end of September. We did not take into account their option positions.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!